Dude where’s my CAR-T? Personalised meds need personalised logistics, says TrakCel
After receiving approval Kymriah, Novartis must prove it can handle the supply chain complexities of manufacturing high-value and time-sensitive CAR-T cell therapies, says logistics firm TrakCel.